Role of B cells in the pathogenesis of systemic sclerosis

Systemic sclerosis (SSc) is an orphan disease characterized by progressive fibrosis of the skin and internal organs. Aside from vasculopathy and fibrotic processes, its pathogenesis involves an aberrant activation of immune cells, among which B cells seem to play a significant role. Indeed, B cell h...

Full description

Saved in:
Bibliographic Details
Published in:La revue de medecine interne 2017-02, Vol.38 (2), p.113-124
Main Authors: Sanges, S., Guerrier, T., Launay, D., Lefèvre, G., Labalette, M., Forestier, A., Sobanski, V., Corli, J., Hauspie, C., Jendoubi, M., Yakoub-Agha, I., Hatron, P.-Y., Hachulla, E., Dubucquoi, S.
Format: Article
Language:English
Subjects:
Animals
Autoantibodies - physiology
B cell
B-Lymphocytes - physiology
BAFF
CD19
Cell Communication - immunology
Humans
Immunotherapy - methods
Molecular Targeted Therapy
Rituximab
Scleroderma, Systemic - immunology
Scleroderma, Systemic - pathology
Scleroderma, Systemic - therapy
Systemic sclerosis
T-Lymphocytes - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Systemic sclerosis (SSc) is an orphan disease characterized by progressive fibrosis of the skin and internal organs. Aside from vasculopathy and fibrotic processes, its pathogenesis involves an aberrant activation of immune cells, among which B cells seem to play a significant role. Indeed, B cell homeostasis is disturbed during SSc: the memory subset is activated and displays an increased susceptibility to apoptosis, which is responsible for their decreased number. This chronic loss of B cells enhances bone marrow production of the naïve subset that accounts for their increased number in peripheral blood. This permanent activation state can be explained mainly by two mechanisms: a dysregulation of B cell receptor (BCR) signaling, and an overproduction of B cell survival signals, B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL). These disturbances of B cell homeostasis induce several functional anomalies that participate in the inflammatory and fibrotic events observed during SSc: autoantibody production (some being directly pathogenic); secretion of pro-inflammatory and pro-fibrotic cytokines (interleukin-6); direct cooperation with other SSc-involved cells [fibroblasts, through transforming growth factor-β (TGF-β) signaling, and T cells]. These data justify the evaluation of anti-B cell strategies as therapeutic options for SSc, such as B cell depletion or blockage of B cell survival signaling.
ISSN:0248-8663
1768-3122
DOI:10.1016/j.revmed.2016.02.016